# OnCo record paper-predomix-metabolome-cancer-rep-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-predomix-metabolome-cancer-rep-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-predomix-metabolome-cancer-rep-2024" ;
  schema:name "Development of a Serum Metabolome-Based Test for Early-Stage Detection of Multiple Cancers"@en ;
  schema:description "PredOmix, an Indian company, reported that a blood test reading thousands of small molecules by mass spectrometry told 30 cancers from no cancer with about 98% accuracy in 6,445 people; the paper gives few further details."@en ;
  schema:url <https://onco.cc/key-papers/paper-predomix-metabolome-cancer-rep-2024/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cnr2.70042>, <https://pubmed.ncbi.nlm.nih.gov/39559978/>, <https://doi.org/10.1038/s41598-023-46553-7> ;
  schema:sameAs <https://doi.org/10.1002/cnr2.70042> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Nagarkar R, Gopichand M, Pal SK, Gupta A, et al." ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/> ;
  onco:drugs <https://onco.cc/drugs/oncoveryx/> ;
  onco:companies <https://onco.cc/companies/predomix/> ;
  onco:journals <https://onco.cc/journals/cancer-reports/> .